FibroGen, Inc. (FGEN)

FibroGen Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	105.73	113.69	155.7	171.22	678.39	126.27
Short-Term Investments	71.87	121.9	266.31	233.97	8.14	407.49
Cash & Cash Equivalents	177.6	235.59	422.01	405.19	686.54	533.76
Cash Growth	-50.11%	-44.17%	4.15%	-40.98%	28.62%	-14.10%
Receivables	37.08	12.55	16.3	17.4	41.88	28.46
Inventory	27.34	41.57	40.44	31.02	16.53	6.89
Other Current Assets	36.15	41.86	14.08	20.45	10.16	133.39
Total Current Assets	278.17	331.56	492.83	474.06	755.11	702.49
Property, Plant & Equipment	76.92	81.22	100.5	119.39	65.3	82.35
Long-Term Investments	7.43	6.95	11.48	173.69	5.04	63.19
Other Long-Term Assets	3.35	3.8	5.28	6.68	1.39	9.37
Total Long-Term Assets	87.7	91.97	117.26	299.76	71.73	154.91
Total Assets	365.87	423.53	610.09	773.82	826.84	857.4
Accounts Payable	4.35	17.96	30.76	26.1	24.79	6.09
Deferred Revenue	159.98	170.3	198.46	202.66	145.02	99.94
Current Debt	15.23	14.08	10.29	10.94	13.52	12.35
Other Current Liabilities	17.17	15.34	34.05	-14.2	-20.14	-15.63
Total Current Liabilities	196.73	217.67	273.56	225.5	163.19	102.75
Long-Term Debt	186.94	189.88	128.93	88.78	26.24	37.61
Other Long-Term Liabilities	168.35	178.18	209.08	230.44	195.96	181.64
Total Long-Term Liabilities	355.29	368.06	338.01	319.21	222.2	219.25
Total Liabilities	552.02	585.73	611.57	544.71	385.39	321.99
Total Debt	202.17	203.96	139.22	99.72	39.76	49.96
Debt Growth	49.55%	46.50%	39.61%	150.79%	-20.41%	-48.58%
Retained Earnings	-1,874.85	-1,841.92	-1,557.69	-1,264.03	-974.01	-784.72
Comprehensive Income	-6.51	-6.88	-5.72	-4.16	-4.5	-0.75
Shareholders' Equity	-228.12	-204.17	-21.45	209.15	422.18	516.14
Net Cash / Debt	-24.57	31.63	282.79	305.47	646.78	483.8
Net Cash / Debt Growth	-	-88.82%	-7.42%	-52.77%	33.69%	-7.72%
Net Cash Per Share	-0.25	0.33	3.02	3.31	7.20	5.58
Working Capital	81.43	113.89	219.26	248.56	591.92	599.75
Book Value Per Share	-2.31	-2.10	-0.23	2.27	4.70	5.96

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).